Abstract
INTRODUCTION
Sinusoidal obstruction syndrome (SOS) is a rare liver vascular injury disease, characterized by damage to small hepatic vessels, affecting particularly the sinusoidal endothelium, which result in complications such as intrahepatic congestion, liver damage, and portal hypertension [1] . SOS was previously called as hepatic venoocclusive disease until some researchers suggested that the main site of toxic injury is hepatic sinusoidal endothelium rather than hepatic veins [2] . Hepatomegaly, ascites, and elevated serum bilirubin levels are the characteristic manifestations of SOS. In addition, severe SOS is associated with a high mortality rate and most deaths result from multi-organ failure [3] . Although liver biopsy is the gold standard for the diagnosis of SOS, leukopenia and poor liver function resulting from hematological diseases or advanced tumors make this operation difficult. The Baltimore criteria, the modified Seattle criteria, and the European Society for Blood and Marrow Transplantation criteria are the three main criteria for diagnosing SOS [4, 5] . However, these criteria are usually appropriated for SOS secondary to haemopoietic stem cell transplantation (HSCT), including a little of clinical information but not involving imaging findings. In recent years, magnetic resonance imaging (MRI) has been increasingly used to detect and evaluate liver diseases. In 2017, Chinese scholars combined the etiologies of SOS in Chinese and proposed the new diagnostic criteria for SOS, namely, the Nanjing criteria. The criteria focus on the diagnosis of SOS caused by pyrrolidine alkaloids (PAs), and incorporate clinical information and imaging findings [6] . Considering the complexity of etiologies and the limitation of liver biopsy, noninvasive imaging methods are significant for SOS differential diagnosis. This systematic review collected the current research on SOS, aiming at generalizing the common etiologies and clinical symptoms of SOS and summarizing the characteristic MRI imaging features for providing more valuable information in SOS early diagnosis.
MATERIALS AND METHODS

Protocol and registration
This systematic review was registered at the international prospective register of systematic reviews platform (PROSPERO; registration number: CRD42019127258). This study followed the recommendations of the Preferred Reporting Items for Systematic Reviews and Meta-Analyses.
Search strategy
We searched all the literature from PubMed, Web of science, Cochrane Library, Wanfang Data, China Knowledge Resource Integrated, and VIP databases. The following set of keywords was used for the English search strategy: [ 
Study selection
All articles related to SOS etiologies, clinical symptoms, and MRI findings were considered. The exclusion criteria were as follows: (1) Duplicate publications among databases; (2) Duplicate publications by the same author; (3) Letter, comments, or conference papers; (4) Reviews; (5) Neither in English nor in Chinese; (6) Not related to human; (7) Not related to this systematic review; and (8) Cannot extract detailed data.
Data extraction
Twenty-nine studies were included in the final analysis, and none of them were randomized controlled trials or cohort studies. We classified the included studies into two categories: Case reports and case series. If detailed data could be extracted for every patient in studies, it would be classified as case reports, otherwise case series.
The following data were collected by two independent investigators: Author, country, published year, patient enrollment, number, age, sex, primary disease, etiology, time of duration, diagnosis method, MRI equipment information, scanning sequence, frequent clinical symptoms, laboratory indexes, and main MRI findings. A third author participated in a disagreement in the findings of two authors, which was solved by discussion.
Study quality
Given the characteristics of our included articles, there was no ready-made quality assessment scale for case reports and case series. Therefore, we referred to some literature [7] and revised the existing quality assessment scale as follows: (1) Notably, case reports were not related to patient enrollment, therefore patient enrollment was not assessed in the study quality.
RESULTS
Search results
A total of 251 articles were initially searched. After removal of duplicates (n = 37), 214 articles were subjected to screening of abstracts and full-texts. Following careful review of abstracts and full-texts, a total of 185 articles were excluded due to not meeting the inclusion criteria. Finally, 29 articles met the inclusion criteria and were included in this systematic review (Figure 1) .
Characteristics of the studies
Among 29 articles included in this systematic review, 20 were in Chinese and 9 in English. According to the case number and information integrity of the literature, 29 articles were classified as either case reports (n = 11) or case series (n = 18).
According to the quality assessment criteria above, we conducted the quality evaluation of all the included literature. The evaluation results are shown in Tables 1  and 2 , and we used two stars to represent the highest quality. The characteristic information of all the patients in 29 studies is shown in Tables 3 and 4. 
Etiologies and clinical symptoms of SOS
Eleven cases reports included 13 individual cases of SOS from 6 counties (USA, Netherlands, UK, Japan, Korea, and China). These patients were admitted from 1999 to 2017. Among the 13 cases, 7 were males and 6 were females (average age: 47.9 ± 18.0; age range: 17-75).
The clinical characteristics of 13 cases are shown in Table 5 . Five cases were secondary to chemotherapy after liver metastases. The chemotherapy cycles ranged from 4 to 8. All the 5 cases presented no obvious clinical symptoms, but the laboratory examination data indicated different degrees of liver damage. In addition, 4 cases were caused by Tusanqi. Ascites was the most common clinical symptom.
Seventeen out of 18 case series were reported by Chinese researchers, and the other one was reported by researchers in Hong Kong, China. All the patients were admitted from 1998 to 2017. Patient enrollment was neither consecutive nor prospective in any case series. Eighteen case series included 497 patients, including 310 males and 187 females. All studies had specific demographic data.
Of the 18 cases series, the patients in 8 cases series were reported to have underlying diseases, including trauma, stroke, alcoholic liver cirrhosis, chronic body pain, hypertension, myocardial infarction, drinking, diabetes, diseases of the respiratory system (tuberculosis and upper respiratory infection), and some diseases related to Chinese medicine (menstrual disorder). SOS in about 465 (93.6%) patients was caused by PAs (Tusanqi), and the time of duration from 10 days to 18 months. Five cases were secondary to tumor chemotherapy or immunotherapy, and four were caused by HSCT. The rest of the patients had no obvious inducing factors.
Not all the 497 patients had detailed records of clinical manifestations and laboratory examination data. Most of the studies recorded the presence or absence of clinical symptoms and described the variation trend of laboratory indicators. Stomach ache, abdominal swelling, and jaundice were the major three symptoms. More serious symptoms were reported in 3 cases series, including hepatic encephalopathy, upper gastrointestinal bleeding, and yellow urine staining. The increase of laboratory indexes, including alanine aminotransferase (ALT), aspartate aminotransferase (AST), gamma-glutamyl transpeptidase (GGT), alkaline phosphatase (ALP), total bilirubin (TBil), and direct bilirubin (DBil), were reported in 16 case series.
Characteristic MRI imaging features
Of all the 510 patients, 250 underwent 256 MRI examinations (12 patients underwent 18 MRI examinations in one study). The scanning sequences included T1WI, T2WI, and multi-phase dynamic enhanced scanning. Among 256 MRI examinations, 8 cases underwent diffusion weighted imaging scans, 22 cases underwent hepatobiliary [17] ** ** ** * ** 2 Kang et al [18] ** ** ** ** ** 3 Yan [20] ** ** ** * ** 4 Yoneda et al [21] ** * * ** * 5 Kawa et al [31] ** * ** ** ** 6 Mortelé et al [8] ** ** * ** ** 7 van den Bosch et al [13] ** ** ** ** ** 8 Marasco et al [9] ** * * * ** 9 Liu et al [32] ** * ** ** * 10 Choi et al [28] ** * ** ** **
11
Arakawa et al [29] ** * ** ** ** *: Quality assessment score.
scans, and 39 cases underwent susceptibility weighted imaging (SWI) scans. In all valid imaging data, the main MRI imaging features were heterogeneous signals on T1WI/T2WI, heterogeneous enhancement, and ascites. All characteristic MRI imaging features are shown in Table 6 .
DISCUSSION
This article systematically reviewed the current available literature related to the etiologies, clinical symptoms, and MRI imaging findings of SOS. In the West, SOS was mostly secondary to HSCT, while some SOS developed in the process of chemotherapy for hepatic metastatic tumor. However, the toxic effects of some special drugs also resulted in the occurrence of SOS, although they have been rarely reported [8, 9] . In the East, especially in China, SOS was often caused by Tusanqi, a plant containing PA that always be used in the herbal medicines. Ascites, abdominal pain and swelling, and jaundice were the common symptoms. ALT, AST, ALP, GGT, and TBil were the main laboratory indicators for diagnosing liver damage. Heterogeneous signals on T1WI/T2WI, heterogeneous enhancement of liver parenchyma, ascites, hepatomegaly, narrowing and blurring of inferior vena cava (IVC) and three main hepatic veins, edema around the portal vein, and gallbladder wall edema were the most common MRI imaging features of SOS.
Our article presents several advantages. First of all, this is the first systematic review that combined clinical information and MRI imaging features of SOS. Second, English and Chinese databases were retrieved at the same time for ensuring the comprehensiveness of this review. To avoid duplicate articles or data, the rigorous studies screening program was also developed. In addition, we formulated the unique quality evaluation criteria based on the nature of the included literature.
SOS was first reported as an early complication of HSCT in 1979 [10] . The cause of the disease is usually associated with sinusoidal endothelial cell cytotoxicity induced by a series of conditioning treatments prior to HSCT. The overall incidence of SOS is related to the diagnosis criteria and type of transplantation, with an incidence of up to 60% [11] . Some risk factors for SOS related to HSCT have been identified, including existing liver disease (chronic hepatitis, liver fibrosis, and cirrhosis), prior history of liver radiant examination, and the effects of some drugs used in the process of conditioning [12] . In addition, Al Jefri et al [4] pointed out that if a patient was too young or too old, or accepted allogeneic transplantation, the possibility of morbidity was greatly increased. In our included literature, van den Bosch et al [13] reported 2 patients who received HSCT due to a history of leukemia. Both of the patients had no history of chronic liver disease, and one of the patients was only 17 years old. However, both of the patients developed severe abdominal pain, hepatomegaly, and ascites approximately 2 wk after receiving HSCT, and the patients who received allogeneic transplantation progressed rapidly to upper gastrointestinal bleeding. Therefore, we believed that the occurrence of these 2 SOS cases is consistent with that mentioned by Al Jefri et al [4] . In recent years, preoperative chemotherapy has been widely used as a primary means of prolonging the survival rate of patients with liver metastasis from gastrointestinal cancer, especially colorectal cancer [14, 15] . Whereas, the use of several cytotoxic agents has been reported to link with irreversible liver damage [16] . Oxaliplatin, as an important composition of the modern chemotherapy regimens, has been proven several times in relation to the incidence of SOS [17] [18] [19] . Indeed, out of 13 patients in 11 case reports, 5 patients were related to chemotherapy for liver metastasis from colorectal cancer and gastric adenocarcinoma [17, 18, 20, 21] . All the patients received oxaliplatin-based adjuvant chemotherapy or S-1 and oxaliplatin (SOX) regimen chemotherapy. Five patients were identified with SOS during the chemotherapy cycle from 4 wk to 11 wk. All the 5 patients had abnormalities in laboratory indicators and moderate to severe splenomegaly. Overman et al [22] have shown that a 50% increase in spleen volume after oxaliplatin chemotherapy can be used as a predictor of SOS. These studies suggested that SOS should be considered if the cancer patient suddenly presented signs of splenomegaly or TBil elevation or persistent thrombocyte decline after a period of chemotherapy.
Furthermore, an animal study revealed that hepatic sinusoidal endothelial cells were equally sensitive to the toxic effects of PAs [23] . It has been reported that PAscontaining medicinal herbs (Tusanqi) can cause SOS [7, 24] . A systematic review [7] has demonstrated that Tusanqi is a principal cause of SOS in China and the disease could develop within several days. Moreover, the elevation levels of bilirubin and ALT were significantly associated with poor outcomes. As showed in our study, 465 (93.6%) of the 497 patients were caused by Tusanqi, and these patients were almost Chinese. Most of them used Tusanqi soaked in wine to relieve body pain or to treat traumatic injury, and some others took it as a nutritional supplement. The duration of intake of Tusanqi ranged from 3 d to 4 years. The differences in onset time may be linked to personal physique and dose and mode of the medicine herbs. In addition, we found that patients caused by Tusanqi more likely presented obvious clinical symptoms. This might be related to the mixed ingredients of the herbal medicines, which might contain a variety of toxic ingredients in addition to PAs. However, we were not sure if intaking PAs-containing herbs for multiple doses as a nutritional supplement was associated with the toxic accumulation and severer symptoms.
In view of the limitations of current diagnostic criteria for SOS, more non-invasive diagnosis methods have to be confirmed. Recently, an increasing number of studies have demonstrated that many characteristic imaging features can improve the early diagnostic efficiency for SOS [25] [26] [27] . Through analyzing MRI features of our included cases, we found that heterogeneous signals on T1WI/T2WI, heterogeneous Li et al [43] China abnormal enhancement of liver parenchyma, some were focused on the second hepatic portal and presented "clover", "claw-shaped", or irregular enhancement, and a few presented hepatic lobe predominant enhancement. "Clover" and "claw-shaped" types of enhancement were the two distinctive MRI imaging features. This may be related to the opening of small blood vessels around the main hepatic veins resulting from obstruction of the hepatic sinus outflow tract, which resulted in an increase in blood supply. Ascites, periportal edema, and gallbladder wall edema may be associated with blockage of portal blood flow and impaired liver function. In addition, several studies [7, 20, 21] reported that the patients who underwent hepatobiliary scans presented diffuse or reticular low signals in the liver parenchyma. Yoneda et al [21] conducted a correlation analysis between organic anion transporting polypeptides 1B3 (OATP1B3) and function of hepatocytes. The results showed that SOS led to hepatocyte function impairment and the signal in the hepatobiliary phase was related to the degree of hepatocyte injury. In addition, Choi et al [28] and Arakawa et al [29] reported SOS cases of focal hepatic lesions during oxaliplatin chemotherapy, which were misdiagnosed as liver metastases. This result suggested that sometimes the focal hepatic lesions should be considered as the occurrence of SOS, and liver biopsy instead of hepatectomy should be used as the initial examination plan. Furthermore, Guo et al [30] indicated that the lesion areas presenting hypo-intensity on SWI and T2*WI were consistent with the abnormal enhancement in the portal vein phase in enhanced MRI. It may be related to the phenomenon that macrophages phagocytose and decompose red blood cells, and the decomposed red blood cells flow into the DISSE gap, which produces a large amount of hemosiderin. This result provided a new possibility for the diagnosis of SOS, especially for the patients with renal insufficiency or allergies to contrast agents. This systematic review had several limitations. First, due to the low incidence of SOS, not enough high-quality literature was included in our study. Second, due to the lack of more complicate data, we were not able to analyze the relationship between MRI features and patient survival prognosis. In addition, some of the included literature was relatively obsolete, and the MRI models and parameters of each center were also different, which may lead to misjudgment of image results due to insufficient understanding of MRI signs.
Summary and outlook
Although with low incidence, SOS still requires clinical attention because of its rapid progression and high mortality. In the West, in addition to being secondary to HSCT, the patients with liver metastasis from colorectal cancer should be highly alert to the occurrence of SOS. Furthermore, the hepatotoxic effects of some special drugs have to be brought to the attention of the public again. In the East, especially in China, while recognizing the efficacy of Chinese herbal medicine, we cannot ignore the potential harm to liver sinusoidal endothelial cells either. Ascites, abdominal pain and swelling, and jaundice are the common symptoms for the diagnosis of SOS. ALT, AST, ALP, GGT, and TBil can be used as predictors of liver function damage induced by SOS. Heterogeneous signals on T1WI/T2WI, heterogeneous enhancement of liver parenchyma, hepatomegaly, narrowing and blurring of intrahepatic IVC and hepatic veins, periportal edema, and gallbladder wall edema are the major MRI features of SOS. In addition, to further improve the non-invasive diagnosis of SOS, more MRI techniques need to be developed and applied, such as hepatobiliary scan of Gd-EOB MRI, SWI, and other functional imaging methods.
criteria, such as the Baltimore criteria and the modified Seattle criteria. However, the diagnosis of SOS only based on clinical criteria is lack of high specificity. In recent years, magnetic resonance imaging (MRI) has been increasingly used in the differential diagnosis of SOS and shows a good prospect. Combing clinical information and MRI features of SOS could greatly improve the efficiency of SOS diagnosis.
Research objectives
The main objective of this systematic review is to summarize the major etiologies, clinical symptoms, and MRI features of SOS.
